<--- Back to Details
First PageDocument Content
Fertility / In vitro fertilisation / Preimplantation genetic diagnosis / Ovarian hyperstimulation / Transvaginal oocyte retrieval / Human chorionic gonadotropin / Assisted reproductive technology / Gonadotropin-releasing hormone antagonist / Gonadotropin-releasing hormone agonist / Fertility medicine / Human reproduction / Medicine
Fertility
In vitro fertilisation
Preimplantation genetic diagnosis
Ovarian hyperstimulation
Transvaginal oocyte retrieval
Human chorionic gonadotropin
Assisted reproductive technology
Gonadotropin-releasing hormone antagonist
Gonadotropin-releasing hormone agonist
Fertility medicine
Human reproduction
Medicine

Experimental research Comparisons of the effects of long-acting and

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Download Document from Source Website

File Size: 456,56 KB

Share Document on Facebook

Similar Documents

Testosterone / Gonadotropin-releasing hormone antagonist / Leuprorelin / Prostate cancer / Moxifloxacin / Gonadotropin-releasing hormone agonist / Hormone replacement therapy / Endocrine system / Medicine / Degarelix

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.

DocID: 16voX - View Document

Pregnancy / Reproduction / Cryobiology / Fertility / In vitro fertilisation / Medicare / Gonadotropin-releasing hormone antagonist / Medicine / Fertility medicine / Human reproduction

IVF/GIFT Elonva® applications Purpose of this form Filling in this form

DocID: UsX0 - View Document

Biology / Ovarian hyperstimulation / Gonadotropin-releasing hormone agonist / In vitro fertilisation / Transvaginal oocyte retrieval / Gonadotropin-releasing hormone antagonist / Polycystic ovary syndrome / Human chorionic gonadotropin / Gonadotropin-releasing hormone / Medicine / Fertility medicine / Human reproduction

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

DocID: JtWT - View Document

Biology / Ovarian hyperstimulation / Gonadotropin-releasing hormone agonist / In vitro fertilisation / Transvaginal oocyte retrieval / Gonadotropin-releasing hormone antagonist / Polycystic ovary syndrome / Human chorionic gonadotropin / Gonadotropin-releasing hormone / Medicine / Fertility medicine / Human reproduction

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

DocID: ISkM - View Document

Biology / Ovarian hyperstimulation / Gonadotropin-releasing hormone agonist / In vitro fertilisation / Transvaginal oocyte retrieval / Gonadotropin-releasing hormone antagonist / Polycystic ovary syndrome / Human chorionic gonadotropin / Gonadotropin-releasing hormone / Medicine / Fertility medicine / Human reproduction

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

DocID: IJbr - View Document